OKYO Pharma Limited (OKYO)
NASDAQ·Healthcare·Biotechnology
$1.58
-0.32%
Mkt Cap $69.35M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Jan 30, 2026 | — | — | — | -$0.07 | -$0.01 | +85.71% | — | — |
| Q1 2025 Jan 29, 2025 | — | — | — | — | -$0.08 | — | — | — |
| Q2 2024 May 13, 2024 | — | — | — | — | -$0.30 | — | — | — |
| Q4 2023 Oct 1, 2023 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2022 Oct 1, 2022 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.47 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.37 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.15 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.06 | — | — | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$0.16 | — | — | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2018 Sep 30, 2018 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2018 Mar 31, 2018 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2017 Sep 30, 2017 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2017 Mar 31, 2017 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2016 Sep 30, 2016 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2016 Mar 31, 2016 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2015 Sep 30, 2015 | — | — | — | — | -$0.00 | — | — | — |